Samsung Bioepis Renews Bid To Invalidate Regeneron Eye Drug Patent on March 22, 2025 eye patent Regeneron Pharmaceuticals Samsung Bioepis + VEGF eye patent Regeneron Pharmaceuticals Samsung Bioepis VEGF